Interest-activity symptom severity predicts response to ketamine infusion in treatment-resistant depression

被引：0
|
作者：
Mu-Hong Chen
Wei-Chen Lin
Hui-Ju Wu
Ya-Mei Bai
Cheng-Ta Li
Shih-Jen Tsai
Chen-Jee Hong
Pei-Chi Tu
Tung-Ping Su
机构：
[1] Taipei Veterans General Hospital,Department of Psychiatry
[2] National Yang-Ming University,Division of Psychiatry, Faculty of Medicine
[3] National Yang-Ming University,Institute of Brain Science
[4] Taipei Veterans General Hospital,Department of Medical Research
[5] Cheng Hsin General Hospital,Department of Psychiatry
来源：
Psychopharmacology | 2021年 / 238卷
关键词：
Ketamine; Treatment-resistant depression; Interest-activity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：857 / 865
页数：8
相关论文
共 50 条
  • [21] In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response
    Holsinger, Tracey
    Riordan, Paul
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (09) : JC105 - JC105
  • [22] Heart Rate Variability in Patients With Treatment-Resistant Depression During Ketamine Infusion
    Soleymani, Taliah
    Greenstein, Dede
    Zarate, Carlos
    Evans, Jennifer
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S185 - S185
  • [23] Beneficial Pre-ECT Ketamine Infusion in a Patient with Treatment-Resistant Depression
    Sultan, Ryan
    Riva-Posse, Patricio
    Garlow, Steven J.
    Schwartz, Ann C.
    PSYCHOSOMATICS, 2014, 55 (04) : 396 - 399
  • [24] Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms
    Uher, R.
    Perlis, R. H.
    Henigsberg, N.
    Zobel, A.
    Rietschel, M.
    Mors, O.
    Hauser, J.
    Dernovsek, M. Z.
    Souery, D.
    Bajs, M.
    Maier, W.
    Aitchison, K. J.
    Farmer, A.
    McGuffin, P.
    PSYCHOLOGICAL MEDICINE, 2012, 42 (05) : 967 - 980
  • [25] Blunted amygdala activity is associated with depression severity in treatment-resistant depression
    Ferri, Jamie
    Eisendrath, Stuart J.
    Fryer, Susanna L.
    Gillung, Erin
    Roach, Brian J.
    Mathalon, Daniel H.
    COGNITIVE AFFECTIVE & BEHAVIORAL NEUROSCIENCE, 2017, 17 (06) : 1221 - 1231
  • [26] Blunted amygdala activity is associated with depression severity in treatment-resistant depression
    Jamie Ferri
    Stuart J. Eisendrath
    Susanna L. Fryer
    Erin Gillung
    Brian J. Roach
    Daniel H. Mathalon
    Cognitive, Affective, & Behavioral Neuroscience, 2017, 17 : 1221 - 1231
  • [27] The cortisol awakening response in treatment-resistant depression is not a biomarker of the clinical response to ketamine
    Naughton, M.
    Allen, A. P.
    Clarke, G.
    Dowling, J.
    Walsh, A.
    Ismail, F.
    Shorten, G.
    Scott, L.
    Cryan, J. F.
    Dinan, T. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S401 - S401
  • [28] Neural Correlates of Treatment Response to Intravenous Ketamine in Adolescents With Treatment-Resistant Depression
    Cullen, Kathryn
    Klimes-Dougan, Bonnie
    Amatya, Palistha
    Thai, Michelle
    Schreiner, Melinda Westlund
    Roback, Mark
    Albott, Sophia
    Ren, Yanan
    Eberly, Lynn
    Lim, Kelvin
    Mueller, Bryon
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S179 - S180
  • [29] Treatment-Resistant Depression and Ketamine Response in a Patient With Bilateral Amygdala Damage
    Scheele, Dirk
    Zimbal, Sophia
    Feinstein, Justin S.
    Delis, Achilles
    Neumann, Claudia
    Mielacher, Clemens
    Philipsen, Alexandra
    Hurlemann, Rene
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (12): : 982 - 986
  • [30] Clinical predictors of antidepressant response to ketamine in unipolar treatment-resistant depression
    Del Sant, L. C.
    Magalhaes, E.
    Lucchese, A. C.
    Palhares Alves, H. N.
    Sarin, L. M.
    Del Porto, J. A.
    Tavares de lacerda, A. L.
    EUROPEAN PSYCHIATRY, 2017, 41 : S525 - S526
12345